Invesaro

Stocks Comparison

ASP Isotopes vs Cabot: revenue, profit, margins and growth compared

ASP Isotopes brought in $23.8M of revenue in fiscal 2025, Cabot $3.7B in fiscal 2025. Revenue changed by +475.5% at ASP Isotopes and -7.0% at Cabot on the year before, so ASP Isotopes grew faster. ASP Isotopes kept -670.2% of its revenue as net profit, Cabot 8.9%. Free cash flow was -$47.4M at ASP Isotopes and $391M at Cabot.

Side by side, latest fiscal year

ASPICBT
Fiscal year endedFY2025 (December 31, 2025)FY2025 (September 30, 2025)
Revenue$23.8M$3.7B
Revenue growth+475.5%-7.0%
Net income-$159.8M$331M
Net margin-670.2%8.9%
Free cash flow-$47.4M$391M
Free cash flow margin-198.9%10.5%
Earnings per share (diluted)-$2.11$6.02
Cash$279.6M$258M
Debt$2.1M$1.1B
Price to earningsn/a13.1
Market value$448.4M$4.1B
Dividend yieldn/a2.23%
Rank by revenue in sector#422 of 451 · Industrials#152 of 451 · Industrials

Over the years

Revenue
ASPI FY2022: $0ASPI FY2023: $433KASPI FY2024: $4.1MASPI FY2025: $23.8MCBT FY2018: $3.2BCBT FY2019: $3.3BCBT FY2020: $2.6BCBT FY2021: $3.4BCBT FY2022: $4.3BCBT FY2023: $3.9BCBT FY2024: $4BCBT FY2025: $3.7BFY18FY19FY20FY21FY22FY23FY24FY25
ASPI $23.8MCBT $3.7B
Net income
ASPI FY2022: -$4.9MASPI FY2023: -$16.3MASPI FY2024: -$32.4MASPI FY2025: -$159.8MCBT FY2018: -$113MCBT FY2019: $157MCBT FY2020: -$238MCBT FY2021: $250MCBT FY2022: $209MCBT FY2023: $445MCBT FY2024: $380MCBT FY2025: $331MFY18FY19FY20FY21FY22FY23FY24FY25
ASPI -$159.8MCBT $331M
Net margin
ASPI FY2023: -3,762.9%ASPI FY2024: -782.4%ASPI FY2025: -670.2%CBT FY2018: -3.5%CBT FY2019: 4.7%CBT FY2020: -9.1%CBT FY2021: 7.3%CBT FY2022: 4.8%CBT FY2023: 11.3%CBT FY2024: 9.5%CBT FY2025: 8.9%FY18FY19FY20FY21FY22FY23FY24FY25
ASPI -670.2%CBT 8.9%
Revenue growth
ASPI FY2024: +857.0%ASPI FY2025: +475.5%CBT FY2019: +2.9%CBT FY2020: -21.7%CBT FY2021: +30.4%CBT FY2022: +26.8%CBT FY2023: -9.0%CBT FY2024: +1.6%CBT FY2025: -7.0%FY19FY20FY21FY22FY23FY24FY25
ASPI +475.5%CBT -7.0%
Free cash flow
ASPI FY2022: -$7.4MASPI FY2023: -$7.7MASPI FY2024: -$26.4MASPI FY2025: -$47.4MCBT FY2018: $69MCBT FY2019: $139MCBT FY2020: $177MCBT FY2021: $62MCBT FY2022: -$111MCBT FY2023: $351MCBT FY2024: $451MCBT FY2025: $391MFY18FY19FY20FY21FY22FY23FY24FY25
ASPI -$47.4MCBT $391M

Fiscal years as each company reports them; the two may end in different months.

Questions about ASP Isotopes and Cabot

Which is bigger by revenue, ASP Isotopes or Cabot?

Cabot is bigger by revenue: $3.7B in fiscal 2025, against $23.8M for ASP Isotopes in fiscal 2025.

Which keeps more of its revenue as profit, ASP Isotopes or Cabot?

ASP Isotopes had a net margin of -670.2% in fiscal 2025; Cabot had 8.9% in fiscal 2025.

Which grew revenue faster, ASP Isotopes or Cabot?

In their latest fiscal years revenue changed by +475.5% at ASP Isotopes and -7.0% at Cabot.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies